nodes	percent_of_prediction	percent_of_DWPC	metapath
Lacosamide—CA6—exocrine gland—uterine cancer	0.0294	0.136	CbGeAlD
Lacosamide—CA3—myometrium—uterine cancer	0.0154	0.0712	CbGeAlD
Lacosamide—CA3—uterine cervix—uterine cancer	0.012	0.0554	CbGeAlD
Lacosamide—CA2—exocrine gland—uterine cancer	0.0101	0.0467	CbGeAlD
Lacosamide—CA3—uterus—uterine cancer	0.01	0.0462	CbGeAlD
Lacosamide—CA9—female reproductive system—uterine cancer	0.00862	0.0397	CbGeAlD
Lacosamide—CA3—vagina—uterine cancer	0.00814	0.0375	CbGeAlD
Lacosamide—SCN3A—decidua—uterine cancer	0.00707	0.0326	CbGeAlD
Lacosamide—SCN3A—renal system—uterine cancer	0.00694	0.032	CbGeAlD
Lacosamide—CA5B—mammalian vulva—uterine cancer	0.00668	0.0308	CbGeAlD
Lacosamide—CA1—renal system—uterine cancer	0.00631	0.0291	CbGeAlD
Lacosamide—CA5B—female reproductive system—uterine cancer	0.00572	0.0264	CbGeAlD
Lacosamide—SCN3A—female reproductive system—uterine cancer	0.00556	0.0256	CbGeAlD
Lacosamide—CA3—lymph node—uterine cancer	0.00527	0.0243	CbGeAlD
Lacosamide—CA5B—vagina—uterine cancer	0.00517	0.0238	CbGeAlD
Lacosamide—CA1—female reproductive system—uterine cancer	0.00505	0.0233	CbGeAlD
Lacosamide—SCN3A—vagina—uterine cancer	0.00503	0.0232	CbGeAlD
Lacosamide—CA4—renal system—uterine cancer	0.00493	0.0227	CbGeAlD
Lacosamide—SCN9A—lymph node—uterine cancer	0.00469	0.0216	CbGeAlD
Lacosamide—CA2—epithelium—uterine cancer	0.00441	0.0203	CbGeAlD
Lacosamide—CA2—smooth muscle tissue—uterine cancer	0.00425	0.0196	CbGeAlD
Lacosamide—CA2—decidua—uterine cancer	0.00416	0.0192	CbGeAlD
Lacosamide—CA2—renal system—uterine cancer	0.00409	0.0188	CbGeAlD
Lacosamide—CA4—female reproductive system—uterine cancer	0.00395	0.0182	CbGeAlD
Lacosamide—CA2—mammalian vulva—uterine cancer	0.00382	0.0176	CbGeAlD
Lacosamide—CA4—female gonad—uterine cancer	0.00359	0.0166	CbGeAlD
Lacosamide—SCN10A—lymph node—uterine cancer	0.00357	0.0164	CbGeAlD
Lacosamide—CA5B—lymph node—uterine cancer	0.00335	0.0154	CbGeAlD
Lacosamide—CA2—female reproductive system—uterine cancer	0.00327	0.0151	CbGeAlD
Lacosamide—SCN3A—lymph node—uterine cancer	0.00325	0.015	CbGeAlD
Lacosamide—Agranulocytosis—Dactinomycin—uterine cancer	0.00301	0.00384	CcSEcCtD
Lacosamide—Discomfort—Progesterone—uterine cancer	0.003	0.00383	CcSEcCtD
Lacosamide—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00298	0.00381	CcSEcCtD
Lacosamide—CA2—female gonad—uterine cancer	0.00298	0.0137	CbGeAlD
Lacosamide—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.00297	0.00379	CcSEcCtD
Lacosamide—Dry mouth—Progesterone—uterine cancer	0.00297	0.00379	CcSEcCtD
Lacosamide—CA2—vagina—uterine cancer	0.00296	0.0136	CbGeAlD
Lacosamide—CA1—lymph node—uterine cancer	0.00295	0.0136	CbGeAlD
Lacosamide—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.00295	0.00377	CcSEcCtD
Lacosamide—Confusional state—Progesterone—uterine cancer	0.00293	0.00375	CcSEcCtD
Lacosamide—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.0029	0.00371	CcSEcCtD
Lacosamide—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.0029	0.0037	CcSEcCtD
Lacosamide—Hepatitis—Dactinomycin—uterine cancer	0.00289	0.0037	CcSEcCtD
Lacosamide—Injection site pain—Epirubicin—uterine cancer	0.00286	0.00366	CcSEcCtD
Lacosamide—Shock—Progesterone—uterine cancer	0.00286	0.00365	CcSEcCtD
Lacosamide—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.00285	0.00364	CcSEcCtD
Lacosamide—Nervous system disorder—Progesterone—uterine cancer	0.00285	0.00364	CcSEcCtD
Lacosamide—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.00284	0.00362	CcSEcCtD
Lacosamide—Skin disorder—Progesterone—uterine cancer	0.00283	0.00361	CcSEcCtD
Lacosamide—Hyperhidrosis—Progesterone—uterine cancer	0.00281	0.00359	CcSEcCtD
Lacosamide—Blood disorder—Epirubicin—uterine cancer	0.0028	0.00357	CcSEcCtD
Lacosamide—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.00275	0.00351	CcSEcCtD
Lacosamide—Erythema multiforme—Dactinomycin—uterine cancer	0.00274	0.00349	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.00273	0.00349	CcSEcCtD
Lacosamide—Toxic epidermal necrolysis—Etoposide—uterine cancer	0.00273	0.00348	CcSEcCtD
Lacosamide—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00272	0.00347	CcSEcCtD
Lacosamide—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.00269	0.00343	CcSEcCtD
Lacosamide—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.00266	0.00339	CcSEcCtD
Lacosamide—Injection site pain—Doxorubicin—uterine cancer	0.00265	0.00338	CcSEcCtD
Lacosamide—Insomnia—Progesterone—uterine cancer	0.00263	0.00336	CcSEcCtD
Lacosamide—Paraesthesia—Progesterone—uterine cancer	0.00261	0.00334	CcSEcCtD
Lacosamide—Shock—Medroxyprogesterone Acetate—uterine cancer	0.00259	0.00331	CcSEcCtD
Lacosamide—Blood disorder—Doxorubicin—uterine cancer	0.00259	0.00331	CcSEcCtD
Lacosamide—Somnolence—Progesterone—uterine cancer	0.00259	0.0033	CcSEcCtD
Lacosamide—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00258	0.0033	CcSEcCtD
Lacosamide—Dyspepsia—Progesterone—uterine cancer	0.00256	0.00327	CcSEcCtD
Lacosamide—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00256	0.00327	CcSEcCtD
Lacosamide—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.00255	0.00325	CcSEcCtD
Lacosamide—Erythema—Dactinomycin—uterine cancer	0.00252	0.00322	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Progesterone—uterine cancer	0.00251	0.00321	CcSEcCtD
Lacosamide—Fatigue—Progesterone—uterine cancer	0.00251	0.0032	CcSEcCtD
Lacosamide—Constipation—Progesterone—uterine cancer	0.00249	0.00318	CcSEcCtD
Lacosamide—Dysarthria—Epirubicin—uterine cancer	0.00247	0.00316	CcSEcCtD
Lacosamide—Neutropenia—Etoposide—uterine cancer	0.00245	0.00312	CcSEcCtD
Lacosamide—Atrioventricular block—Epirubicin—uterine cancer	0.00241	0.00308	CcSEcCtD
Lacosamide—Feeling abnormal—Progesterone—uterine cancer	0.0024	0.00306	CcSEcCtD
Lacosamide—Gait disturbance—Epirubicin—uterine cancer	0.0024	0.00306	CcSEcCtD
Lacosamide—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00238	0.00304	CcSEcCtD
Lacosamide—Coordination abnormal—Epirubicin—uterine cancer	0.00238	0.00304	CcSEcCtD
Lacosamide—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00237	0.00302	CcSEcCtD
Lacosamide—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00234	0.00299	CcSEcCtD
Lacosamide—Anaemia—Dactinomycin—uterine cancer	0.00233	0.00297	CcSEcCtD
Lacosamide—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00232	0.00296	CcSEcCtD
Lacosamide—Stevens-Johnson syndrome—Etoposide—uterine cancer	0.00231	0.00295	CcSEcCtD
Lacosamide—Urticaria—Progesterone—uterine cancer	0.00231	0.00295	CcSEcCtD
Lacosamide—CA4—lymph node—uterine cancer	0.00231	0.0106	CbGeAlD
Lacosamide—Body temperature increased—Progesterone—uterine cancer	0.0023	0.00294	CcSEcCtD
Lacosamide—Dysarthria—Doxorubicin—uterine cancer	0.00229	0.00292	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00228	0.00291	CcSEcCtD
Lacosamide—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00227	0.0029	CcSEcCtD
Lacosamide—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00225	0.00288	CcSEcCtD
Lacosamide—Atrioventricular block—Doxorubicin—uterine cancer	0.00223	0.00285	CcSEcCtD
Lacosamide—Gait disturbance—Doxorubicin—uterine cancer	0.00222	0.00283	CcSEcCtD
Lacosamide—Hepatobiliary disease—Etoposide—uterine cancer	0.00221	0.00282	CcSEcCtD
Lacosamide—Coordination abnormal—Doxorubicin—uterine cancer	0.0022	0.00281	CcSEcCtD
Lacosamide—Agranulocytosis—Etoposide—uterine cancer	0.00218	0.00278	CcSEcCtD
Lacosamide—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00217	0.00277	CcSEcCtD
Lacosamide—Hypersensitivity—Progesterone—uterine cancer	0.00214	0.00274	CcSEcCtD
Lacosamide—Discomfort—Dactinomycin—uterine cancer	0.00212	0.00271	CcSEcCtD
Lacosamide—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00209	0.00267	CcSEcCtD
Lacosamide—Asthenia—Progesterone—uterine cancer	0.00209	0.00266	CcSEcCtD
Lacosamide—Hypoaesthesia—Etoposide—uterine cancer	0.00208	0.00266	CcSEcCtD
Lacosamide—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00208	0.00266	CcSEcCtD
Lacosamide—Pruritus—Progesterone—uterine cancer	0.00206	0.00263	CcSEcCtD
Lacosamide—Diarrhoea—Progesterone—uterine cancer	0.00199	0.00254	CcSEcCtD
Lacosamide—Erythema multiforme—Etoposide—uterine cancer	0.00198	0.00253	CcSEcCtD
Lacosamide—Eye disorder—Etoposide—uterine cancer	0.00196	0.0025	CcSEcCtD
Lacosamide—Cardiac disorder—Etoposide—uterine cancer	0.00194	0.00248	CcSEcCtD
Lacosamide—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00194	0.00248	CcSEcCtD
Lacosamide—Dizziness—Progesterone—uterine cancer	0.00192	0.00246	CcSEcCtD
Lacosamide—CA2—lymph node—uterine cancer	0.00191	0.00883	CbGeAlD
Lacosamide—Immune system disorder—Etoposide—uterine cancer	0.00189	0.00242	CcSEcCtD
Lacosamide—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00189	0.00241	CcSEcCtD
Lacosamide—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00186	0.00238	CcSEcCtD
Lacosamide—Vomiting—Progesterone—uterine cancer	0.00185	0.00236	CcSEcCtD
Lacosamide—Rash—Progesterone—uterine cancer	0.00183	0.00234	CcSEcCtD
Lacosamide—Dermatitis—Progesterone—uterine cancer	0.00183	0.00234	CcSEcCtD
Lacosamide—Headache—Progesterone—uterine cancer	0.00182	0.00233	CcSEcCtD
Lacosamide—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.0018	0.0023	CcSEcCtD
Lacosamide—Fatigue—Dactinomycin—uterine cancer	0.00177	0.00226	CcSEcCtD
Lacosamide—Muscle spasms—Etoposide—uterine cancer	0.00175	0.00224	CcSEcCtD
Lacosamide—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00174	0.00223	CcSEcCtD
Lacosamide—Nausea—Progesterone—uterine cancer	0.00173	0.00221	CcSEcCtD
Lacosamide—Diplopia—Epirubicin—uterine cancer	0.0017	0.00217	CcSEcCtD
Lacosamide—Osteoarthritis—Epirubicin—uterine cancer	0.0017	0.00217	CcSEcCtD
Lacosamide—Feeling abnormal—Dactinomycin—uterine cancer	0.00169	0.00216	CcSEcCtD
Lacosamide—Anaemia—Etoposide—uterine cancer	0.00168	0.00215	CcSEcCtD
Lacosamide—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00168	0.00214	CcSEcCtD
Lacosamide—Affect lability—Epirubicin—uterine cancer	0.00167	0.00213	CcSEcCtD
Lacosamide—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00166	0.00212	CcSEcCtD
Lacosamide—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00166	0.00212	CcSEcCtD
Lacosamide—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00165	0.00211	CcSEcCtD
Lacosamide—Vertigo—Etoposide—uterine cancer	0.00164	0.00209	CcSEcCtD
Lacosamide—Body temperature increased—Dactinomycin—uterine cancer	0.00163	0.00208	CcSEcCtD
Lacosamide—Mood swings—Epirubicin—uterine cancer	0.00161	0.00205	CcSEcCtD
Lacosamide—Loss of consciousness—Etoposide—uterine cancer	0.0016	0.00205	CcSEcCtD
Lacosamide—Ataxia—Epirubicin—uterine cancer	0.0016	0.00204	CcSEcCtD
Lacosamide—Diplopia—Doxorubicin—uterine cancer	0.00157	0.00201	CcSEcCtD
Lacosamide—Osteoarthritis—Doxorubicin—uterine cancer	0.00157	0.00201	CcSEcCtD
Lacosamide—Liver function test abnormal—Epirubicin—uterine cancer	0.00157	0.002	CcSEcCtD
Lacosamide—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00157	0.002	CcSEcCtD
Lacosamide—Chest pain—Etoposide—uterine cancer	0.00155	0.00198	CcSEcCtD
Lacosamide—Affect lability—Doxorubicin—uterine cancer	0.00155	0.00197	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.00154	0.00197	CcSEcCtD
Lacosamide—Discomfort—Etoposide—uterine cancer	0.00153	0.00196	CcSEcCtD
Lacosamide—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.00153	0.00195	CcSEcCtD
Lacosamide—Hypersensitivity—Dactinomycin—uterine cancer	0.00151	0.00193	CcSEcCtD
Lacosamide—Confusional state—Etoposide—uterine cancer	0.0015	0.00192	CcSEcCtD
Lacosamide—Mood swings—Doxorubicin—uterine cancer	0.00149	0.0019	CcSEcCtD
Lacosamide—Ataxia—Doxorubicin—uterine cancer	0.00148	0.00189	CcSEcCtD
Lacosamide—Asthenia—Dactinomycin—uterine cancer	0.00147	0.00188	CcSEcCtD
Lacosamide—Eosinophilia—Epirubicin—uterine cancer	0.00145	0.00185	CcSEcCtD
Lacosamide—Liver function test abnormal—Doxorubicin—uterine cancer	0.00145	0.00185	CcSEcCtD
Lacosamide—Skin disorder—Etoposide—uterine cancer	0.00145	0.00185	CcSEcCtD
Lacosamide—Hyperhidrosis—Etoposide—uterine cancer	0.00144	0.00184	CcSEcCtD
Lacosamide—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.00141	0.00181	CcSEcCtD
Lacosamide—Diarrhoea—Dactinomycin—uterine cancer	0.00141	0.0018	CcSEcCtD
Lacosamide—Neutropenia—Epirubicin—uterine cancer	0.00137	0.00175	CcSEcCtD
Lacosamide—Eosinophilia—Doxorubicin—uterine cancer	0.00134	0.00172	CcSEcCtD
Lacosamide—Paraesthesia—Etoposide—uterine cancer	0.00134	0.00171	CcSEcCtD
Lacosamide—Somnolence—Etoposide—uterine cancer	0.00132	0.00169	CcSEcCtD
Lacosamide—Vomiting—Dactinomycin—uterine cancer	0.00131	0.00167	CcSEcCtD
Lacosamide—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.0013	0.00166	CcSEcCtD
Lacosamide—Rash—Dactinomycin—uterine cancer	0.0013	0.00166	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Etoposide—uterine cancer	0.00128	0.00164	CcSEcCtD
Lacosamide—Fatigue—Etoposide—uterine cancer	0.00128	0.00164	CcSEcCtD
Lacosamide—Constipation—Etoposide—uterine cancer	0.00127	0.00162	CcSEcCtD
Lacosamide—Neutropenia—Doxorubicin—uterine cancer	0.00127	0.00162	CcSEcCtD
Lacosamide—Hepatobiliary disease—Epirubicin—uterine cancer	0.00124	0.00158	CcSEcCtD
Lacosamide—Feeling abnormal—Etoposide—uterine cancer	0.00123	0.00157	CcSEcCtD
Lacosamide—Nausea—Dactinomycin—uterine cancer	0.00122	0.00156	CcSEcCtD
Lacosamide—Agranulocytosis—Epirubicin—uterine cancer	0.00122	0.00156	CcSEcCtD
Lacosamide—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.0012	0.00153	CcSEcCtD
Lacosamide—Bradycardia—Epirubicin—uterine cancer	0.0012	0.00153	CcSEcCtD
Lacosamide—Urticaria—Etoposide—uterine cancer	0.00118	0.00151	CcSEcCtD
Lacosamide—Body temperature increased—Etoposide—uterine cancer	0.00118	0.0015	CcSEcCtD
Lacosamide—Hepatitis—Epirubicin—uterine cancer	0.00117	0.0015	CcSEcCtD
Lacosamide—Hypoaesthesia—Epirubicin—uterine cancer	0.00117	0.00149	CcSEcCtD
Lacosamide—Connective tissue disorder—Epirubicin—uterine cancer	0.00115	0.00147	CcSEcCtD
Lacosamide—Hepatobiliary disease—Doxorubicin—uterine cancer	0.00114	0.00146	CcSEcCtD
Lacosamide—Agranulocytosis—Doxorubicin—uterine cancer	0.00113	0.00144	CcSEcCtD
Lacosamide—Erythema multiforme—Epirubicin—uterine cancer	0.00111	0.00142	CcSEcCtD
Lacosamide—Bradycardia—Doxorubicin—uterine cancer	0.00111	0.00141	CcSEcCtD
Lacosamide—Eye disorder—Epirubicin—uterine cancer	0.0011	0.0014	CcSEcCtD
Lacosamide—Hypersensitivity—Etoposide—uterine cancer	0.0011	0.0014	CcSEcCtD
Lacosamide—Tinnitus—Epirubicin—uterine cancer	0.00109	0.0014	CcSEcCtD
Lacosamide—Cardiac disorder—Epirubicin—uterine cancer	0.00109	0.00139	CcSEcCtD
Lacosamide—Hepatitis—Doxorubicin—uterine cancer	0.00109	0.00139	CcSEcCtD
Lacosamide—Hypoaesthesia—Doxorubicin—uterine cancer	0.00108	0.00138	CcSEcCtD
Lacosamide—Asthenia—Etoposide—uterine cancer	0.00107	0.00136	CcSEcCtD
Lacosamide—Connective tissue disorder—Doxorubicin—uterine cancer	0.00107	0.00136	CcSEcCtD
Lacosamide—Immune system disorder—Epirubicin—uterine cancer	0.00106	0.00135	CcSEcCtD
Lacosamide—Pruritus—Etoposide—uterine cancer	0.00105	0.00134	CcSEcCtD
Lacosamide—Mental disorder—Epirubicin—uterine cancer	0.00103	0.00131	CcSEcCtD
Lacosamide—Erythema multiforme—Doxorubicin—uterine cancer	0.00103	0.00131	CcSEcCtD
Lacosamide—Erythema—Epirubicin—uterine cancer	0.00102	0.00131	CcSEcCtD
Lacosamide—Diarrhoea—Etoposide—uterine cancer	0.00102	0.0013	CcSEcCtD
Lacosamide—Eye disorder—Doxorubicin—uterine cancer	0.00102	0.0013	CcSEcCtD
Lacosamide—Tinnitus—Doxorubicin—uterine cancer	0.00101	0.00129	CcSEcCtD
Lacosamide—Cardiac disorder—Doxorubicin—uterine cancer	0.00101	0.00129	CcSEcCtD
Lacosamide—Flatulence—Epirubicin—uterine cancer	0.00101	0.00129	CcSEcCtD
Lacosamide—Dizziness—Etoposide—uterine cancer	0.000984	0.00126	CcSEcCtD
Lacosamide—Muscle spasms—Epirubicin—uterine cancer	0.000982	0.00125	CcSEcCtD
Lacosamide—Immune system disorder—Doxorubicin—uterine cancer	0.000981	0.00125	CcSEcCtD
Lacosamide—Vision blurred—Epirubicin—uterine cancer	0.000963	0.00123	CcSEcCtD
Lacosamide—Mental disorder—Doxorubicin—uterine cancer	0.000952	0.00122	CcSEcCtD
Lacosamide—Vomiting—Etoposide—uterine cancer	0.000946	0.00121	CcSEcCtD
Lacosamide—Erythema—Doxorubicin—uterine cancer	0.000946	0.00121	CcSEcCtD
Lacosamide—Anaemia—Epirubicin—uterine cancer	0.000945	0.00121	CcSEcCtD
Lacosamide—Agitation—Epirubicin—uterine cancer	0.000939	0.0012	CcSEcCtD
Lacosamide—Rash—Etoposide—uterine cancer	0.000938	0.0012	CcSEcCtD
Lacosamide—Dermatitis—Etoposide—uterine cancer	0.000937	0.0012	CcSEcCtD
Lacosamide—Headache—Etoposide—uterine cancer	0.000932	0.00119	CcSEcCtD
Lacosamide—Flatulence—Doxorubicin—uterine cancer	0.000932	0.00119	CcSEcCtD
Lacosamide—Vertigo—Epirubicin—uterine cancer	0.000918	0.00117	CcSEcCtD
Lacosamide—Syncope—Epirubicin—uterine cancer	0.000916	0.00117	CcSEcCtD
Lacosamide—Muscle spasms—Doxorubicin—uterine cancer	0.000909	0.00116	CcSEcCtD
Lacosamide—Palpitations—Epirubicin—uterine cancer	0.000903	0.00115	CcSEcCtD
Lacosamide—Loss of consciousness—Epirubicin—uterine cancer	0.000898	0.00115	CcSEcCtD
Lacosamide—Vision blurred—Doxorubicin—uterine cancer	0.000891	0.00114	CcSEcCtD
Lacosamide—Nausea—Etoposide—uterine cancer	0.000884	0.00113	CcSEcCtD
Lacosamide—Anaemia—Doxorubicin—uterine cancer	0.000874	0.00112	CcSEcCtD
Lacosamide—Chest pain—Epirubicin—uterine cancer	0.00087	0.00111	CcSEcCtD
Lacosamide—Agitation—Doxorubicin—uterine cancer	0.000869	0.00111	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000864	0.0011	CcSEcCtD
Lacosamide—Discomfort—Epirubicin—uterine cancer	0.00086	0.0011	CcSEcCtD
Lacosamide—Dry mouth—Epirubicin—uterine cancer	0.000851	0.00109	CcSEcCtD
Lacosamide—Vertigo—Doxorubicin—uterine cancer	0.00085	0.00108	CcSEcCtD
Lacosamide—Syncope—Doxorubicin—uterine cancer	0.000848	0.00108	CcSEcCtD
Lacosamide—Confusional state—Epirubicin—uterine cancer	0.000841	0.00107	CcSEcCtD
Lacosamide—Palpitations—Doxorubicin—uterine cancer	0.000836	0.00107	CcSEcCtD
Lacosamide—Loss of consciousness—Doxorubicin—uterine cancer	0.000831	0.00106	CcSEcCtD
Lacosamide—Shock—Epirubicin—uterine cancer	0.000821	0.00105	CcSEcCtD
Lacosamide—Nervous system disorder—Epirubicin—uterine cancer	0.000818	0.00104	CcSEcCtD
Lacosamide—Skin disorder—Epirubicin—uterine cancer	0.00081	0.00103	CcSEcCtD
Lacosamide—Hyperhidrosis—Epirubicin—uterine cancer	0.000806	0.00103	CcSEcCtD
Lacosamide—Chest pain—Doxorubicin—uterine cancer	0.000805	0.00103	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000799	0.00102	CcSEcCtD
Lacosamide—Discomfort—Doxorubicin—uterine cancer	0.000795	0.00102	CcSEcCtD
Lacosamide—Dry mouth—Doxorubicin—uterine cancer	0.000787	0.00101	CcSEcCtD
Lacosamide—Confusional state—Doxorubicin—uterine cancer	0.000778	0.000994	CcSEcCtD
Lacosamide—Shock—Doxorubicin—uterine cancer	0.000759	0.00097	CcSEcCtD
Lacosamide—Nervous system disorder—Doxorubicin—uterine cancer	0.000757	0.000966	CcSEcCtD
Lacosamide—Insomnia—Epirubicin—uterine cancer	0.000754	0.000963	CcSEcCtD
Lacosamide—Skin disorder—Doxorubicin—uterine cancer	0.00075	0.000957	CcSEcCtD
Lacosamide—Paraesthesia—Epirubicin—uterine cancer	0.000749	0.000956	CcSEcCtD
Lacosamide—Hyperhidrosis—Doxorubicin—uterine cancer	0.000746	0.000953	CcSEcCtD
Lacosamide—Somnolence—Epirubicin—uterine cancer	0.000741	0.000947	CcSEcCtD
Lacosamide—Dyspepsia—Epirubicin—uterine cancer	0.000734	0.000938	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Epirubicin—uterine cancer	0.00072	0.00092	CcSEcCtD
Lacosamide—Fatigue—Epirubicin—uterine cancer	0.000719	0.000918	CcSEcCtD
Lacosamide—Constipation—Epirubicin—uterine cancer	0.000713	0.000911	CcSEcCtD
Lacosamide—Insomnia—Doxorubicin—uterine cancer	0.000698	0.000891	CcSEcCtD
Lacosamide—Paraesthesia—Doxorubicin—uterine cancer	0.000693	0.000885	CcSEcCtD
Lacosamide—Feeling abnormal—Epirubicin—uterine cancer	0.000687	0.000878	CcSEcCtD
Lacosamide—Somnolence—Doxorubicin—uterine cancer	0.000686	0.000876	CcSEcCtD
Lacosamide—Dyspepsia—Doxorubicin—uterine cancer	0.000679	0.000868	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000666	0.000851	CcSEcCtD
Lacosamide—Fatigue—Doxorubicin—uterine cancer	0.000665	0.00085	CcSEcCtD
Lacosamide—Urticaria—Epirubicin—uterine cancer	0.000663	0.000846	CcSEcCtD
Lacosamide—Constipation—Doxorubicin—uterine cancer	0.00066	0.000843	CcSEcCtD
Lacosamide—Body temperature increased—Epirubicin—uterine cancer	0.000659	0.000842	CcSEcCtD
Lacosamide—Feeling abnormal—Doxorubicin—uterine cancer	0.000636	0.000812	CcSEcCtD
Lacosamide—Hypersensitivity—Epirubicin—uterine cancer	0.000614	0.000785	CcSEcCtD
Lacosamide—Urticaria—Doxorubicin—uterine cancer	0.000613	0.000783	CcSEcCtD
Lacosamide—Body temperature increased—Doxorubicin—uterine cancer	0.00061	0.000779	CcSEcCtD
Lacosamide—Asthenia—Epirubicin—uterine cancer	0.000598	0.000764	CcSEcCtD
Lacosamide—Pruritus—Epirubicin—uterine cancer	0.00059	0.000754	CcSEcCtD
Lacosamide—Diarrhoea—Epirubicin—uterine cancer	0.000571	0.000729	CcSEcCtD
Lacosamide—Hypersensitivity—Doxorubicin—uterine cancer	0.000569	0.000726	CcSEcCtD
Lacosamide—Asthenia—Doxorubicin—uterine cancer	0.000554	0.000707	CcSEcCtD
Lacosamide—Dizziness—Epirubicin—uterine cancer	0.000552	0.000704	CcSEcCtD
Lacosamide—Pruritus—Doxorubicin—uterine cancer	0.000546	0.000697	CcSEcCtD
Lacosamide—Vomiting—Epirubicin—uterine cancer	0.00053	0.000677	CcSEcCtD
Lacosamide—Diarrhoea—Doxorubicin—uterine cancer	0.000528	0.000674	CcSEcCtD
Lacosamide—Rash—Epirubicin—uterine cancer	0.000526	0.000672	CcSEcCtD
Lacosamide—Dermatitis—Epirubicin—uterine cancer	0.000525	0.000671	CcSEcCtD
Lacosamide—Headache—Epirubicin—uterine cancer	0.000522	0.000667	CcSEcCtD
Lacosamide—Dizziness—Doxorubicin—uterine cancer	0.00051	0.000652	CcSEcCtD
Lacosamide—Nausea—Epirubicin—uterine cancer	0.000495	0.000633	CcSEcCtD
Lacosamide—Vomiting—Doxorubicin—uterine cancer	0.000491	0.000627	CcSEcCtD
Lacosamide—Rash—Doxorubicin—uterine cancer	0.000487	0.000621	CcSEcCtD
Lacosamide—Dermatitis—Doxorubicin—uterine cancer	0.000486	0.000621	CcSEcCtD
Lacosamide—Headache—Doxorubicin—uterine cancer	0.000483	0.000617	CcSEcCtD
Lacosamide—Nausea—Doxorubicin—uterine cancer	0.000458	0.000585	CcSEcCtD
